Original Article | Published:

Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates

Journal of Perinatology volume 37, pages 927931 (2017) | Download Citation

Abstract

Objective:

The objective of the study was to study the performance of cerebrospinal fluid (CSF) procalcitonin as a marker for bacterial meningitis in neonates, and to determine its optimal ‘cutoff’ in CSF that can be called significant for the diagnosis.

Study Design:

Neonates qualifying for lumbar puncture were prospectively studied. Procalcitonin and established CSF parameters were recorded.

Results:

At a cut-off value of 0.33 ng ml−1, CSF procalcitonin had a sensitivity of 0.92, specificity of 0.87, with positive and negative likelihood ratios of 7.13 and 0.092, respectively. The area under the curve for different CSF parameters was: 0.926 (0.887 to 0.964) (P<0.001) for procalcitonin, 0.965 (0.956 to 0.974) for total leukocyte count, 0.961 (0.94 to 0.983) for neutrophil count, 0.874 (0.825 to 0.923) for protein, 0.946 (0.914 to 0.978) for sugar and 0.92 (0.955 to 0.992) for CSF:serum sugar ratio. The lumbar puncture was traumatic in 36 (21.4%) patients; out of these 15 (41.7%) had bacterial meningitis and 21 (58.3%) had no meningitis. In traumatic lumbar tap group, the median (IQR) CSF procalcitonin in patients with and without meningitis was 1.41 (0.32-3.42) ng/ml and 0.21(0.20-0.31) ng/ml respectively (p<0.05).

Conclusions:

Procalcitonin measurement has diagnostic efficiency similar to the established CSF markers. Routine assessment of procalcitonin in clean non-contaminated CSF may not yield additional information, but it may have clinical utility in situations where diagnosis of meningitis is in dilemma, as in the case of blood contamination of CSF in traumatic lumbar punctures.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , . Meningitis en neonates: bench to bedside. Clin Perinatol 2010; 37: 655–676.

  2. 2.

    , , . New understandings on the pathophysiology of bacterial meningitis. Curr Opin Infect Dis 2010; 23(3): 217–223.

  3. 3.

    , , , , , et al. Neonatal bacterial meningitis: 444 cases in 7 years. Pediatr Infect Dis J 2011; 30: 212–217.

  4. 4.

    , , . Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 2003; 88(3): F173–F178.

  5. 5.

    , . Clinical outcome of neonatal bacterial meningitis according to birth weight. Arq Neuropsiquiatr 2007; 65: 1149–1153.

  6. 6.

    , , . Effect of meningitis in infancy on school-leaving examination results. Arch Dis Child 2007; 92(11): 959–962.

  7. 7.

    , , , , , et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 130(1): e8–15.

  8. 8.

    , , , . Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012; 379(9814):445–452.

  9. 9.

    , , . Should a neonate with possible late onset infection always have a lumbar puncture? Arch Dis Child 2006; 91(1): 75–76.

  10. 10.

    , , , , , et al. Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? Pediatrics 2006; 117(4): 1094–1100.

  11. 11.

    , , , , , . Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid white blood cell count. Pediatr Infect Dis J 2008; 27(12): 1047–1051.

  12. 12.

    , , , , . Diagnosis of neonatal sepsis: a clinical and laboratory challenge. Clin Chem 2004; 50: 279–287.

  13. 13.

    , , , , , . Procalcitonin in pediatrics. Adv Clin Chem 2013; 59: 203–263.

  14. 14.

    , , . Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4(10): 620–630.

  15. 15.

    , , , , , et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49: 60–68.

  16. 16.

    , , . Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 2003; 92: 243–245.

  17. 17.

    , , , , . Umbilical cord blood serum procalcitonin concentration in the diagnosis of early neonatal infection. J Perinatol 2003; 23: 148–153.

  18. 18.

    , , , . Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 2001; 29(4): 209–212.

  19. 19.

    , . The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cerebrospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis 2002; 22: 155–165.

  20. 20.

    , . Corrections for leukocytes and percent of neutrophils do not match observations in blood-contaminated cerebrospinal fluid and have no value over uncorrected cells for diagnosis. Pediatr Infect Dis J 2006; 25(1): 8–11.

  21. 21.

    , . Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 1984; 4: 137–150.

  22. 22.

    , , , , , et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J 1999; 18(10): 875–881.

  23. 23.

    , , , , , et al. Procalcitonin in cerebrospinal fluid in meningitis: a prospective diagnostic study. Brain Behav 2016; 6(11): e00545.

  24. 24.

    , , , , , et al. Can procalcitonin in cerebrospinal fluid be a diagnostic tool for meningitis? J Clin Lab Anal 2015; 29(3): 169–174.

  25. 25.

    , , , , , et al. Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation. J Neuroimmunol 2007; 189: 169–174.

  26. 26.

    , , . Immune responses in neonates. Exp Rev Clin Immunol 2014; 10(9): 1171–1184.

  27. 27.

    , , . Physiology and genetics of procalcitonin. Physiol Res 2000; 49: S57–S61.

  28. 28.

    , , , , . Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 2004; 116: 849–853.

  29. 29.

    , . Procalcitonin for the clinical laboratory: a review. Pathology 2007; 39(4): 383–390.

  30. 30.

    . Understanding diagnostic tests 3: receiver operating characteristiccurves. Acta Paediatr 2007; 96: 644–647.

  31. 31.

    , , , , , . Procalcitonin in young febrile infants for the detection of serious bacterial infections. Pediatrics 2008; 122(4): 701–710.

  32. 32.

    , , , , , et al. Diagnostic value of procalcitonin in well-appearing young febrile infants. Pediatrics 2012; 130: 815–822.

  33. 33.

    , , , , , . High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341(8844): 515–518.

  34. 34.

    , , , , . Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89(4): 1512–1525.

  35. 35.

    , , , , , et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intens Care Med 2007; 33(3): 477–484.

  36. 36.

    , , , , . Procalcitonin: a marker of neonatal sepsis. J Trop Pediatr 2002; 48: 10–14.

  37. 37.

    , , . Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children. Pediatr Crit Care Med 2003; 4(2): 264–266.

  38. 38.

    , , , , , et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001; 84(4): 332–336.

  39. 39.

    , , , , . Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28(6): 1828–1832.

  40. 40.

    , , . Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112(5): 1054–1060.

  41. 41.

    , , , , , . Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007; 26(8): 672–677.

  42. 42.

    , , , , . Procalcitonin is persistently increased among children with poor outcome from bacterial sepsis. Pediatr Crit Care Med 2003; 4(1): 21–25.

  43. 43.

    , , , , . Distinguishing cerebrospinal fluid abnormalities in children with bacterial meningitis and traumatic lumbar puncture. J Infect Dis 1990; 162(1): 251–254.

  44. 44.

    , , . Interpretation of traumatic lumbar punctures: who can go home? Pediatrics 2003; 111(3): 525–528.

Download references

Author information

Affiliations

  1. Department of Pediatrics and Neonatology, Sher-I-Kashmir Institute of Medical Sciences Hospital, Srinagar, India

    • Z Reshi
    • , M Nazir
    • , W Wani
    • , M Malik
    • , J Iqbal
    •  & S Wajid

Authors

  1. Search for Z Reshi in:

  2. Search for M Nazir in:

  3. Search for W Wani in:

  4. Search for M Malik in:

  5. Search for J Iqbal in:

  6. Search for S Wajid in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to M Nazir.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/jp.2017.73